Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reference1505
- Development stage
- Discontinued
01
Overview
Reference1505 is a comparator drug used in clinical trials evaluating the efficacy and safety of Sunpharma1505 for the treatment of active rheumatoid arthritis. The specific identity, mechanism of action, and composition of Reference1505 are not publicly disclosed in available sources. It is likely a reference or standard product (possibly prednisolone or methylprednisolone acetate) used as a control arm in these studies, but this cannot be confirmed with certainty from current data[1][4][5]. There is no evidence that Reference1505 has been approved for any indication or that it represents an innovative pharmaceutical entity.
- Brand names
- Reference1505Reference-1505Reference 1505
- Other names
- Reference-1505Reference1505Reference 1505
Beyond the preview
Go deeper on Reference1505.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reference1505.